| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $166K | +0.8% |
| SG&A Expense | $2.0M | +12.1% |
| Operating Income | -$3.4M | -9.8% |
| Pre-tax Income | -$3.6M | -6.6% |
| Net Income | -$3.6M | -6.6% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.8M | +165.9% |
| Inventory | $29K | +322.2% |
| Current Assets | $1.9M | +152.4% |
| Total Assets | $2.6M | +70.4% |
| Current Liabilities | $10.4M | +8.6% |
| Total Liabilities | $10.6M | +9.4% |
| Stockholders' Equity | -$8.0M | +1.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.8M | +2.7% |
| Capital Expenditures | $5K | +27.2% |
| Investing Cash Flow | $438K | — |
| Financing Cash Flow | $2.5M | +7102.3% |
| Free Cash Flow | -$1.8M | +2.7% |